Cardiac Surgery, KU Leuven University Hospitals Leuven, Leuven, Belgium.
Cardiovascular Surgery, Mount Sinai Hospital, New York, New York, USA.
Heart. 2023 May 15;109(11):832-838. doi: 10.1136/heartjnl-2022-321840.
Differences in indication and technique make a randomised comparison between valve-sparing root replacement (VSRR) and personalised external aortic root support (PEARS) challenging. We performed a propensity score (PS)-matched comparison of PEARS and VSRR for syndromic root aneurysm.
Patients in the PEARS 200 Database and Aortic Valve Insufficiency and ascending aorta Aneurysm InternATiOnal Registry (undergoing VSRR) with connective tissue disease operated electively for root aneurysm <60 mm with aortic regurgitation (AR) <1/4 were included. Using a PS analysis, 80 patients in each cohort were matched. Survival, freedom from reintervention and from AR ≥2/4 were estimated using a Kaplan-Meier analysis.
Median follow-up was 25 and 55 months for 159 PEARS and 142 VSRR patients. Seven (4.4%) patients undergoing PEARS required an intervention for coronary injury or impingement, resulting in one death (0.6%). After VSRR, there were no early deaths, 10 (7%) reinterventions for bleeding and 1 coronary intervention. Survival for matched cohorts at 5 years was similar (PEARS 98% vs VSRR 99%, p=0.99). There was no difference in freedom from valve or ascending aortic/arch reintervention between matched groups. Freedom from AR ≥2/4 at 5 years in the matched cohorts was 97% for PEARS vs 92% for VSRR (p=0.55). There were no type A dissections.
VSRR and PEARS offer favourable mid-term survival, freedom from reintervention and preservation of valve function. Both treatments deserve their place in the surgical repertoire, depending on a patient's disease stage. This study is limited by its retrospective nature and different follow-ups in both cohorts.
由于在适应证和技术方面存在差异,因此比较保留瓣膜的主动脉根部替换术(VSRR)和个性化外部主动脉根部支撑(PEARS)具有挑战性。我们对综合征性根部动脉瘤的患者进行了倾向评分(PS)匹配的 PEARS 和 VSRR 比较。
纳入了 PEARS 200 数据库和主动脉瓣关闭不全及升主动脉动脉瘤国际注册研究(接受 VSRR)中接受择期手术治疗的结缔组织疾病患者,这些患者的根部动脉瘤<60mm,主动脉瓣反流(AR)<1/4。使用 PS 分析,每个队列匹配 80 例患者。使用 Kaplan-Meier 分析估计生存、无再次干预和 AR≥2/4 的无事件生存率。
159 例 PEARS 患者和 142 例 VSRR 患者的中位随访时间分别为 25 个月和 55 个月。7 例(4.4%)接受 PEARS 的患者需要进行冠状动脉损伤或撞击的干预,导致 1 例死亡(0.6%)。VSRR 后无早期死亡,10 例(7%)因出血和 1 例冠状动脉介入而需要再次干预。匹配队列的 5 年生存率相似(PEARS 98%对 VSRR 99%,p=0.99)。两组间在瓣膜或升主动脉/弓部再次干预方面无差异。匹配队列的 5 年 AR≥2/4 的无事件生存率为 PEARS 组 97%,VSRR 组 92%(p=0.55)。无 A 型夹层。
VSRR 和 PEARS 提供了有利的中期生存率、无再次干预和保留瓣膜功能。两种治疗方法都应根据患者的疾病阶段在手术治疗中占有一席之地。本研究受到回顾性研究设计和两组随访时间不同的限制。